Abvc biopharma announces termination of two contracts

Fremont, ca, june 10, 2022 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced that two contracts entered into in the last 45 days have been terminated.
ABVC Ratings Summary
ABVC Quant Ranking